Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dying nerves cause even more harm after spinal cord injury

13.11.2003


A new study in rats has found that after severe spinal cord injury, molecules intended to help nerves communicate can attack the tissue surrounding the initial injury and cause further damage.



Interestingly, this latent, or secondary, injury develops over days and even weeks after the initial injury. It also appears to cause larger, more debilitating lesions in the spinal cord, said Randy Christensen, the study’s lead author and a postdoctoral researcher in neuroscience at Ohio State University.

Receiving the initial brunt of the secondary trauma seem to be the neurons, or the cells in gray matter. As time passes, however, tissue in the white matter is also destroyed by secondary damage. Oligodendrocytes, the main cell type in white matter, begin to self-destruct during the secondary injury.


Oligodendrocytes protect the white matter’s axons – long, skinny tails attached to nerve cells that carry nerve cell messages throughout the body.

"These long, fragile extensions of nerve cells are probably very vulnerable," Christensen said.

The researchers presented their results Nov. 12 in New Orleans at the annual Society for Neuroscience meeting. Christensen conducted the study with Jacqueline Bresnahan, a professor of neuroscience at Ohio State, and Michael Beattie, the chair of Ohio State’s neuroscience department.

The researchers injected glutamate, tumor necrosis factor-alpha (TNFa) or both molecules into the spinal cords of healthy, uninjured rats. Glutamate is a neurotransmitter, while TNFa is a potent cell stimulator – its function includes stimulating the body’s immune response after injury. Both are released in dangerously high concentrations at the site of a spinal cord injury.

Christensen and his colleagues suspect that glutamate and TNFa work in tandem, essentially over-stimulating the tissue surrounding the original site of damage, causing the surrounding cells to “go into shock” and die.

In these experiments, the rats’ spinal cords weren’t injured, but the injections of glutamate and TNFa mimicked the effects of secondary injury. A group of control rats was injected with albumin, an innocuous protein, to make sure the injection itself hadn’t caused the secondary injury.

The researchers found a delayed reaction . . . the axons near the injection site began breaking two days after injection. In related work, these researchers have found evidence of axons breaking up to fourteen weeks after an injury.

"While we’re not sure why the axons begin to break so long after the initial injection, the cells meant to help the wound heal may get overly excited – so much so that they destroy the axons," Christensen said. “Another possibility is that the protective oligodendrocytes take a couple of days to die, finally exposing the bare axons to damage.

"Preventing over-stimulation caused by glutamate and TNFa together may be a viable strategy for therapeutic intervention after human spinal cord injury."

While there was noticeable nerve cell loss and tissue damage in gray matter 90 minutes after injections, the axons were not affected at this point in time.

By day two after the injection, however, there were large lesions in the white matter surrounding the injection site as well as noticeable damage to the axons.

"The time course is pretty important, because in spinal cord injury, many of the cells don’t die until long after the initial injury," Christensen said. "Dying neurons might release glutamate and TNFa, and that release eventually kills neighboring nerve cells, oligodendrocytes, and axons."

This research was supported by a grant from the National Institutes of Health.

Holly Wagner | OSU
Further information:
http://researchnews.osu.edu/archive/sfnspine.htm
http://medicine.osu.edu/neuroscience/index.html

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>